Fatal liver disease despite sustained eradication of recurrent hepatitis C virus requiring liver retransplantation

Transplantation

Volumn 82, Issue 2, 2006, Pages 286-288

  Mukherjee, Sandeep ^a,b  

^a NEBRASKA MEDICAL CENTER   (United States)

^b Section of Gastroenterology and Hepatology   (United States)

Author keywords

Decompensated cirrhosis; Interferon; Recurrent hepatitis C virus; Retransplantation; Ribavirin; Sustained eradication

Indexed keywords

ANTIVIRUS AGENT; CYCLOSPORIN A; INTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; TACROLIMUS;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; ERADICATION THERAPY; FATIGUE; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPENIA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MALAISE; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RECURRENT DISEASE; RETRANSPLANTATION; THROMBOCYTOPENIA;

EMBOLIZATION, THERAPEUTIC; FATAL OUTCOME; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; REOPERATION; SPLENIC DISEASES; VIRAL LOAD;

EID: 33746397487     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000226178.71720.43     Document Type: Article

References (15)

1. Neumann UP, Berg T, Bahra M, et al. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up. Transplantation 2004; 77: 226.
2. Neff GW, O'Brien CB, Nery J, et al. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection. Liver Transplant 2004; 10: 1497.
3. Charlton M. Natural history of hepatitis C and outcomes following liver transplantation. Clin Liv Dis 2003; 7: 585.
4. Samuel D. Antiviral treatment of recurrent hepatitis C after liver transplantation: the need for a multifaceted approach. Hepatology 2005; 41: 436.
5. Biggins SW, Terrault NA. Treatment of recurrent hepatitis C after liver transplantation. Clin Liv Dis 2005; 9: 505.
6. Kim WR, Poterucha JJ, Porayko MK, et al. Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation 1996; 62: 1802.
7. Castera L, Chouteau P, Hezode C, et al. Hepatitis C virus-induced hepatocellular steatosis. Am J Gastroenterol 2005; 100: 711.
8. Poordad F, Gisg R, Wakil A, et al. De novo non-alcoholic fatty liver disease following liver transplantation. Am J Transplant 2003; 3: 1413.
9. Bizollon T, Ahmed SN, Radenne S, et al. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence. Gut 2003; 52: 283.
10. Abdelmalek MF, Firpi RJ, Soldevila-Pico C, et al. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Liver Transpl 2004; 10: 199.
11. Vento S, Cainelli F, Renzini C, et al. Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance. Lancet 1997; 350: 1298.
12. Mukherjee S, Rogge J, Weaver LK, et al. De novo cryptogenic hepatitis after sustained eradication of hepatitis C following liver transplantation. Transplant Proc 2004; 36: 1494.
13. Carmel-Haggain, Fiel MI, Gaddipati HC, et al. Recurrent hepatitis C after retransplantation: Factors affecting graft and patient outcomes. Liver Transpl 2005; 11: 1567-73.
14. Watt KD, Lyden ER, McCashland TM. Poor survival after liver retransplantation: is hepatitis C to blame? Liver Transpl 2003; 9: 1019.
15. Forman LM. To transplant or not to retransplant recurrent hepatitis C and liver failure? Clin Liv Dis 2003; 7: 615.